Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectation and raises 2025 ...

Don't sweat roaming charges on your next trip abroad. GigSky and Visa are offering a 15-day free eSim trial so you can access ...

Mobile, hiking its price target from $265 to $280. This bold move maintains an 'Overweight' rating, signaling strong ...

A worrying Android attack has left millions with infected devices - now is a good time to check you are not a victim.